Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.

Ehsan Nazemalhosseini-MojaradRoya Kishani FarahaniMaryam MehriziKaveh BaghaeiMohammad Yaghoob TaleghaniMina GolmohammadiNoshad PeyravianSara AshtariMohmad Amin PourhoseingholiHamid Asadzadeh AghdaeiMohammad Reza Zali

Published in: Journal of gastrointestinal cancer (2020)

The present study revealed that BRAF and KRAS mutations were not related to the worse overall survival, while KRAS mutation can be a prognostic factor for overall survival in sporadic microsatellite-stable (MSS) status in Iranian CRC patients.

Keyphrases

prognostic factors
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
patient reported outcomes
late onset
genetic diversity
amyotrophic lateral sclerosis